Wu & Hakami investigating COVID-19 therapies

Yuntao Wu, Professor, Molecular and Microbiology, and Ramin Hakami, Associate Professor, School of Systems Biology, are conducting studies of COVID-19 therapies. Recent work from several independent groups has demonstrated that K18-hACE2 transgenic mice serve as an appropriate animal model for studying COVID-19. Published research has shown that ACE2 is the human cell entry receptor for…

NCCN shares new guidance principles for vaccinating people with cancer against COVID-19

PLYMOUTH MEETING, PA [January 22, 2021] — The National Comprehensive Cancer Network® (NCCN®) put out new information today to provide guidance for COVID-19 vaccinations in people with cancer. The nonprofit alliance of leading cancer centers created an NCCN COVID-19 Vaccine Committee that includes top hematology and oncology experts with particular expertise in infectious diseases, vaccine…

Consenting for treatment in advance to reduce leaving the hospital against medical advice among patients with addiction – Experts debate pros and cons

January 22, 2021 – Patients with substance use disorders (SUDs) being treated for serious medical conditions are more likely to leave the hospital against medical advice (AMA) than those without addiction. A special type of contract with healthcare providers might enable patients to consent in advance to life-saving medical care – even if they later…